The Neurology business unit is focused on treatments for stroke, traumatic brain injury, vascular dementia, Alzheimer’s and Parkinson’s disease. We look to continually develop safer and easier to use products in this field and our portfolio encompasses proprietary delivery devices such as pens and pumps as well as drug products.

For example, for patients with advanced Parkinson’s disease, we offer Apomorphine for intermittent off episodes in the form of a single injection pen/cartridge or as a continuous infusion using a mini pump.